AT-Patch (ATP-C130/ATP-C70) vs VX1+
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require extended, non-invasive ambulatory ECG monitoring for patients in their daily lives. This tool is ideal for detecting intermittent arrhythmias over several days or weeks, providing comprehensive data for diagnosis without requiring the patient to remain in a clinical setting.
View AT-Patch (ATP-C130/ATP-C70) →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist seeking real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation or tachycardia. This software helps identify abnormal electrograms to guide more precise ablation, aiming to improve procedural success rates and patient outcomes.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | VX1+ |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)AT-Patch prioritizes patient comfort and ease of use with its compact, lightweight, and shower-proof design, requiring no charging or electrode replacement during up to 14 days of continuous monitoring. The accompanying smartphone app further enhances patient usability for live ECG viewing and symptom recording. While VX1+ offers a simple interface for clinicians, AT-Patch's features directly improve the patient experience in a broader, less specialized context.
Clinical Value
VX1+VX1+ provides real-time AI-powered assistance to electrophysiologists during complex cardiac ablation procedures, directly aiding in the identification of abnormal electrograms. This real-time decision support during a critical interventional procedure has an immediate and direct impact on procedural success and patient outcomes. While AT-Patch offers valuable long-term diagnostic data, VX1+ actively assists in a high-stakes treatment scenario.
Pricing & Value
TieNeither AT-Patch nor VX1+ has publicly available pricing information; both typically involve direct sales to medical institutions or distributors. Without any transparent pricing details, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
VX1+VX1+ explicitly highlights its compatibility and integration with major existing EP recording and 3D mapping systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system. This demonstrates a strong focus on seamless integration into established hospital workflows for specialized procedures. While AT-Patch's analysis software is on-premise, its broader integration capabilities are not detailed.
Innovation
VX1+VX1+ represents a significant innovation by providing real-time AI-powered guidance during live, complex cardiac ablation procedures, directly influencing critical decision-making in an interventional setting. This application of AI in a high-stakes surgical environment pushes the boundaries of AI in healthcare. AT-Patch's innovation lies in patient-centric remote monitoring and AI-driven diagnostics, which is also valuable but less disruptive in its application.
Support & Docs
TieBoth products provide evidence of user manuals and documentation. AT-Patch has user manuals for the device and PC software, while VX1+ also has a system user manual. There is no publicly available information to indicate that one offers significantly more extensive support services or documentation than the other.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | VX1+ |
|---|---|---|
| Name | AT-Patch (ATP-C130/ATP-C70) | VX1+ |
| Company | ATsens Co. | Volta Medical |
| Tagline | Ambulatory ECG Monitor for Continuous Cardiac Monitoring | Transforming EP Data into AI Solutions |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Surgical AI |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Key Features (Primary Function) | Up to 14 days of continuous ECG monitoring with AI analysis for arrhythmia detection. | AI-powered software for real-time identification of abnormal electrograms during cardiac ablation procedures. |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and VX1+.